SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-16-000168
Filing Date
2016-07-06
Accepted
2016-07-06 09:05:36
Documents
3
Period of Report
2016-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201607068xkdocb.htm 8-K 38565
2 PRESS RELEASE pdli-201607068xkex991b.htm EX-99.1 20865
3 pdl-logoa04a01a01a01a02a14.jpg GRAPHIC 59351
  Complete submission text file 0000882104-16-000168.txt   142511
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 161752554
SIC: 2836 Biological Products, (No Diagnostic Substances)